ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $785,000 | -52.3% | 56,552 | -3.5% | 0.00% | -50.0% |
| Q4 2021 | $1,644,000 | -26.7% | 58,605 | -11.2% | 0.01% | -25.0% |
| Q3 2021 | $2,242,000 | -17.4% | 65,967 | -0.7% | 0.01% | -20.0% |
| Q2 2021 | $2,714,000 | +57.9% | 66,427 | +55.6% | 0.01% | +42.9% |
| Q1 2021 | $1,719,000 | -27.5% | 42,704 | +6.5% | 0.01% | -36.4% |
| Q4 2020 | $2,371,000 | +62.2% | 40,092 | +33.4% | 0.01% | +37.5% |
| Q3 2020 | $1,462,000 | +11.4% | 30,064 | +10.8% | 0.01% | +14.3% |
| Q2 2020 | $1,312,000 | +96.7% | 27,128 | +12.9% | 0.01% | +40.0% |
| Q1 2020 | $667,000 | +297.0% | 24,027 | +328.5% | 0.01% | +400.0% |
| Q4 2019 | $168,000 | -6.1% | 5,607 | -3.3% | 0.00% | 0.0% |
| Q3 2019 | $179,000 | +645.8% | 5,800 | +1060.0% | 0.00% | – |
| Q2 2019 | $24,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |